Information Links
Previous Issues Volume 6, Issue 1 - 2021
Esophageal Granular Cell Tumor
Vedat Goral1, Sila Yilmaz Erozbek2, Kerem Mert Goral3, Burcu Saka2
1Istanbul Medipol University Medical School Department of Gastroenterology, Istanbul.
2Istanbul Medipol University Medical School Department of Pathology, Istanbul
3Yeditepe Medipol University School of Medicine, Istanbul
*Corresponding author: Prof. Dr. Vedat Goral Istanbul Medipol University, Medipol Mega Hospital Goztepe Mah. 2309 Sk. No: 6 Bagcilar 34214 Istanbul, Turkey. Tel: 0090 533 5256614. E-mail: [email protected]
Received Date: December 08, 2021
Publication Date: December 21, 2021
Copyright: Goral V. ©2021.
Citation: Goral V. (2021). Esophageal Granular Cell Tumor. Mathews J Gastroenterol Hepatol. 6(1):16.
ABSTRACT
Esophageal granular cell tumors (GCTs) are rare, often benign tumors of neurogenic origin. Granular cell tumors (GCTs), first described by Abrikossoff in 1926, are rare tumors that occur in various parts of the body [1,2]. They are generally observed in the gastrointestinal tract, less commonly in the thyroid, respiratory tract, female urogenital tract, nervous system, breast, and gastrointestinal (GI) tract [1,2]. Tumors in the gastrointestinal tract represent only 6-10% of all granular cell tumors, especially the esophagus. In 30-60% of these cases, the most common location is the esophagus [1,3]. These neoplasms are usually solitary and are multifocal lesions in 10% of cases. Although their clinical course is relatively benign, approximately 2% of GCTs are malignant.
Keywords: Espohageal granular tumor, Esophagus, Endoscopy
